angiotensin-ii

Documents about angiotensin-ii

• Early Angiotensin II in the Emergency Department#1279748ClinicalTrials.gov
• Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.#1444235ClinicalTrials.gov
• Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia#831630ClinicalTrials.gov
• Renin and Renal Biomarker Response to Angiotensin II#897636ClinicalTrials.gov
• Angiotensin II Antagonism of TGF-Beta 1#1211348ClinicalTrials.gov
• Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease#948231Repositorio de Universidad Autónoma de Chile.
• Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker#1409600ClinicalTrials.gov
• Angiotensin II Infusion Leads to Aortic Dissection in LRP8 Deficient Mice#235338HAL (France)
• Angiotensin II in Liver Transplantation#834523ClinicalTrials.gov
• Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline#1308092ClinicalTrials.gov
• Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma#1352763ClinicalTrials.gov
• Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)#1378795ClinicalTrials.gov
• Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)#1365112ClinicalTrials.gov
• Postoperative Pain and Angiotensin II Receptor Antagonists#454117ClinicalTrials.gov
• Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database#947907Repositorio de Universidad Autónoma de Chile.
• Angiotensin II Receptor: Molecular Cloning, Functions, and Regulation#70532J-STAGE (Japan)
• Angiotensin II for Septic Shock Treatment#807491ClinicalTrials.gov
• Angiotensin II Pathway and Postoperative Hypoxemia#992389ClinicalTrials.gov
• Angiotensin II for Distributive Shock#1452641ClinicalTrials.gov
• Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock#839981ClinicalTrials.gov
• Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)#828056ClinicalTrials.gov
• Guideline Directed Medical Therapy in Patients With Heart Failure#1378613ClinicalTrials.gov
• Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients#1030342ClinicalTrials.gov
• Angiotensin II Blockade for Chronic Allograft Nephropathy#238275ClinicalTrials.gov
• Human Intestinal Amino Acid Absorption and the Role of a Local RAS#1320434ClinicalTrials.gov
• Cardioprotective mechanisms against reperfusion injury in acute myocardial infarction: targeting angiotensin II receptors#250639IRIS
• RAAS Optimization for Acute CHF Patients#1397377ClinicalTrials.gov
• Angiotensin in Septic Kidney Injury Trial#1487274ClinicalTrials.gov
• Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes#1475106ClinicalTrials.gov
• MiR-378 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting AKT2#70373J-STAGE (Japan)
• Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy#875209ClinicalTrials.gov
• Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives#1047730ClinicalTrials.gov
• Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure#1377525ClinicalTrials.gov
• Study of Renin-angiotensin System in Mechanically Ventilated Subjects#897408ClinicalTrials.gov
• New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering#366667ClinicalTrials.gov
• Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation#1363982ClinicalTrials.gov
• Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II#897139ClinicalTrials.gov
• A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.#805635ClinicalTrials.gov
• Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics#910524ClinicalTrials.gov
• Plasma Angiotensin II Levels In Women With Type 2 Diabetes With Or Without Hypertension#930366Acta Interna: The Journal of Internal Medicine
• Angiotensin Receptor Blockers in Aortic Stenosis#1262742ClinicalTrials.gov
• A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)#136157ClinicalTrials.gov
• Prognostic Interest of Vasorin in Septic Shock#1087025ClinicalTrials.gov
• Codelist for: "Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study"#274972LSHTM Data Compass
• Effect of Candesartan in Alcoholic Liver Fibrosis#1292711ClinicalTrials.gov
• RASi for Preventing Postoperative Recurrence of Stage II/III Colon Cancer#1125876ClinicalTrials.gov
• Angiotensin II Type 1 Receptor Autoantibodies (AT1AA): Cause or Consequence of Human Primary Aldosteronism?#647608Research Data Unipd
• Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria#1451360ClinicalTrials.gov
• Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients#442020ClinicalTrials.gov
• Evaluation of Effects of Exercise Training and ARB in DM Patients#1045807ClinicalTrials.gov